What's New ? - 2019

What's New ? - 2019

On-farm antimicrobial usage in broilers and turkey production in the USA, 2013 – 2017

6 August, 2019

The U.S. Poultry & Egg Association announces the release of the first-ever report quantifying the U.S. poultry industry’s on-farm antimicrobial use. The new report shows dramatic reductions of turkey and broiler chicken antimicrobial use over a five-year timeframe.
This report represents data regarding the use of antimicrobials from 2013 to 2017 throughout the lifetime of U.S. broiler chickens and turkeys. Data regarding antimicrobial use among broiler chickens and turkeys was reported from the hatchery until the day of harvest through the five-year collection period of 2013–2017. For 2017, data representing more than 7.5 billion broiler chickens (about 90% of annual U.S. chicken production by the major companies) and 160 million turkeys (about 80% of annual U.S. turkey production by the major companies) were submitted, analyzed and are reported within this study.
Key Changes Among Broiler Chickens Over the Five-Year Period
- Hatchery gentamicin use in broiler chicks decreased approximately 74% between 2013 and 2017
- Necrotic enteritis, a clostridial disease of chickens, remains one of the most important diseases of chickens that requires antimicrobial therapy
- In-feed virginiamycin use decreased approximately 60% between 2013 and 2017
- In-feed tetracycline use decreased approximately 95% between 2013 and 2017
- In-feed avilamycin use increased in 2017; a drug for the prevention of necrotic enteritis. Avilamycin, was approved for use in 2016 and had a large increase in use in 2017
- Water-soluble penicillin use decreased approximately 21% between 2013 and 2017 and approximately 42% since the peak in 2015
- Water-soluble sulfonamide use decreased approximately 72% between 2013 and 2017
Key Changes Among Turkeys Over the Five-Year Period
-
Gangrenous dermatitis, a clostridial disease of turkeys, remains one of the most important diseases of turkeys that requires antimicrobial therapy
- Colibacillosis, a broad category of E. coli diseases that affect turkeys, results in much of the antimicrobial use in feed and water
- Hatchery gentamicin use in turkey poults decreased approximately 42% between 2013 and 2017
- Hatchery ceftiofur use in turkey poults went to zero between 2013 and 2017
- In-feed tetracycline use decreased approximately 67% between 2013 and 2017
This report documents that the poultry industry of the U.S. has made substantial progress in reducing its use of antimicrobials.

Related Links
Link Full report